Rocket Pharma finalizes Dr. Patel separation; consulting through Dec 2026 with $582K retainer

ROCKET PHARMACEUTICALS, INC.

Dr. Kinnari Patel receives $482,040 lump-sum severance (10 months salary) and $30,045 healthcare allowance.
She stays on paid garden leave through Dec 31, 2025; then consulting until Dec 31, 2026 for $582,156 retainer.
Patel retains restricted stock units and options during the consulting period under existing plans.
Accrued PTO payout of $102,480; 2025 bonus eligibility subject to company performance.
Payments conditioned on release of claims, non-disparagement, and restrictive covenant compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.